News, Research and Lifestyle Articles


Dry Eye and Glaucoma

February 2019 - Dry eye is a common problem affecting between 5% and 35% (up to 50% in DEWS II) of the population. It is a complex condition with multiple factors that contribute to an unstable and imbalanced tear film.



Branded or Generic: Which Eye Drops Do You Choose?


January 2019 - The use of generic versus branded medication is an ongoing topic of debate among all healthcare practitioners. Are generic drugs just as effective as branded medication? 


CERA research may spark glaucoma ‘sub-group’ treatment

January 2019 - Australian neurodegeneration researchers have received a $750,000 grant to further investigate links between changes in mitochondrial DNA and optic nerve diseases.


Glaucoma Drug Pipeline to Increase Compliance

January 2019 - New therapies to treat glaucoma, anticipated for release in 2020, are expected to improve patient compliance thanks to their novel mechanisms of action (MOA), according to data and analytics company, GlobalData.


Australia’s first World Glaucoma Congress to host free screenings

December 2018 - Relatives of glaucoma patients will have access to free screening clinics and leading specialists at next year’s World Glaucoma Congress, the first time the event has been held in Australia.


Indian doctors find meditation helps treat glaucoma

December 2018 - Meditation can help lower eye pressure in glaucoma sufferers, according to an Indian study claiming to have revealed the most comprehensive link between the two. However, they stressed “patients must not stop using glaucoma medications and must regularly follow up and get their eye check-up done at least once a year by a qualified eye specialist.”


Allergan supports Glaucoma Australia with 3-year sponsorship

November 2018 - Allergan Australia and Glaucoma Australia are pleased to announce a platinum sponsorship agreement that represents funding support of AU$300,000 for the charity over a three year period. The focus for the partnership will be on early detection and treatment adherence to help prevent irreversible blindness and boosting education and support available to existing patients.


Volunteers sought for new visual field study 

November 2018 - A new research study that focuses on developing improved methods of testing for visual field damage due to glaucoma is being undertaken by researchers at the Department of Optometry and Vision Sciences, University of Melbourne.


George & Matilda, IBM Collaborate on AI for Glaucoma 

November 2018 - George and Matilda Eyecare and IBM Research Australia will work together to determine how retinal fundus photos, optical coherence tomography (OCT) images, and AI algorithms can be used to inform and potentially help guide practitioners in detecting glaucoma.


Australian tech could end need for daily eye drops

October 2018 - A clinical-stage Australian biotechnology company, PolyActiva, has recruited patients into its Phase I clinical trial for a new ocular implant that could improve the daily lives of millions of glaucoma patients.